1. Home
  2. PI vs ELVN Comparison

PI vs ELVN Comparison

Compare PI & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Impinj Inc.

PI

Impinj Inc.

HOLD

Current Price

$172.65

Market Cap

4.0B

Sector

Technology

ML Signal

HOLD

Logo Enliven Therapeutics Inc.

ELVN

Enliven Therapeutics Inc.

HOLD

Current Price

$58.82

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PI
ELVN
Founded
2000
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
4.2B
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
PI
ELVN
Price
$172.65
$58.82
Analyst Decision
Buy
Strong Buy
Analyst Count
8
5
Target Price
$176.38
$43.40
AVG Volume (30 Days)
479.3K
1.0M
Earning Date
04-29-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.17
EPS
N/A
N/A
Revenue
$122,633,000.00
N/A
Revenue This Year
$4.26
N/A
Revenue Next Year
$25.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$87.96
$14.79
52 Week High
$247.06
$62.32

Technical Indicators

Market Signals
Indicator
PI
ELVN
Relative Strength Index (RSI) 62.16 62.42
Support Level $130.37 $25.63
Resistance Level $178.87 $62.32
Average True Range (ATR) 9.74 2.85
MACD 2.14 -0.19
Stochastic Oscillator 79.35 64.44

Price Performance

Historical Comparison
PI
ELVN

About PI Impinj Inc.

Impinj Inc operates a platform that enables wireless connectivity to everyday items by delivering each item's identity, location, and authenticity to business and consumer applications. Its platform includes endpoint integrated circuits (ICs) product, a miniature radios-on-a-chip, which attach to and identify their host items; and connectivity layer that comprises readers, gateways, and reader ICs to wirelessly identify, locate, authenticate, and engage endpoints via RAIN, as well as provide power to and communicate bidirectionally with endpoint ICs. Geographically, the company has a business presence in the Americas, Asia Pacific, Europe, Middle East and Africa, of which key revenue is derived from the operations in the Asia Pacific region.

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

Share on Social Networks: